<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02892526</url>
  </required_header>
  <id_info>
    <org_study_id>2012/CPRC/PLAIES VITALES/MART</org_study_id>
    <nct_id>NCT02892526</nct_id>
  </id_info>
  <brief_title>Wound Vitality Markers in Forensic Pathology</brief_title>
  <acronym>PLAIES VITALES</acronym>
  <official_title>Wound Vitality Markers in Forensic Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to determine intrinsic properties of various immunohistochemical markers
      (FVIIIra, CD15, CD30, tryptase, TNFα, IL-1β, TGFα et TGFβ1) for diagnosis of vital wound,
      alone and in association (evaluation of sensibility with surgery wounds and evaluation of
      specificity with post-mortem wounds).

      Secondary purposes are to measure the minimum time to obtain a positive labeling in vital
      wounds, and to evaluate inter-observer reproducibility of vitality diagnosis with different
      markers. Expression of microRNA miR 9, miR 21 et miR 198 will be also studied.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensibility of markers for vitality diagnosis</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of markers for vitality diagnosis</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minimum time to obtain a labeling (between incision and devascularization)</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coefficient of inter-observer correlation of vitality diagnosis (for reproducibility analysis)</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression level of miR 9 by qRT-PCR</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression level of miR 21 by qRT-PCR</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression level of miR 198 by qRT-PCR</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">57</enrollment>
  <condition>Wound</condition>
  <arm_group>
    <arm_group_label>Vital wounds</arm_group_label>
    <description>from abdominoplasty of alive persons</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-mortem wounds</arm_group_label>
    <description>from autopsy of deceased persons</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Abdominoplasty with exeresis of cutaneous tissue</intervention_name>
    <arm_group_label>Vital wounds</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Collection of cutaneous tissue</intervention_name>
    <arm_group_label>Post-mortem wounds</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cutaneous tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients operated in Plastic and Reconstructive Surgery and Maxillofacial Surgery
        departments at CHRU Nancy for therapeutic abdominoplasty.

        Deceased patients, whose medico-scientific autopsies are performed for diagnosis in Anatomy
        and Pathological Cytology or Legal Medicine departments.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Alive persons:

        - Abdominoplasty

        Deceased persons:

        - Medico-scientific autopsy for diagnosis

        Exclusion Criteria:

        Alive persons:

          -  Fragmented sample with non-visible banks

          -  Cutaneous pathology

        Deceased persons:

          -  Persons under protection

          -  Medico-legal obstacle

          -  Cutaneous pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent MARTRILLE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Médecine Légale - CHRU de Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurent MARTRILLE</last_name>
    <email>l.martrille@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2016</study_first_submitted>
  <study_first_submitted_qc>September 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2016</study_first_posted>
  <last_update_submitted>September 2, 2016</last_update_submitted>
  <last_update_submitted_qc>September 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

